Vanguard Group Inc Repligen Corp Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,079,894 shares of RGEN stock, worth $589 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,079,894

Previous 5,101,090 0.42%

Holding current value

$589 Million

Previous $734 Million 11.97%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$127.24 - $174.24 $2.7 Million - $3.69 Million	-21,196 Reduced 0.42%	5,079,894 $646 Million
Q4 2024 Feb 11, 2025	BUY	$123.41 - $160.92 $7 Million - $9.13 Million	56,723 Added 1.12%	5,101,090 $734 Million
Q3 2024 Nov 13, 2024	SELL	$119.79 - $167.35 $2.64 Million - $3.68 Million	-22,002 Reduced 0.43%	5,044,367 $751 Million
Q2 2024 Aug 13, 2024	SELL	$120.0 - $182.95 $4.04 Million - $6.16 Million	-33,644 Reduced 0.66%	5,066,369 $639 Million
Q1 2024 May 10, 2024	BUY	$170.78 - $208.42 $3.71 Million - $4.53 Million	21,719 Added 0.43%	5,100,013 $938 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $3.81 Million - $6.19 Million	33,404 Added 0.66%	5,078,294 $913 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $1.6 Million - $2.03 Million	-11,508 Reduced 0.23%	5,044,890 $802 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $3.53 Million - $4.6 Million	-25,521 Reduced 0.5%	5,056,398 $715 Million
Q1 2023 Jul 14, 2023	BUY	$154.26 - $198.1 $3,702 - $4,754	24 Added 0.0%	5,081,919 $856 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $19 Million - $24.4 Million	-123,260 Reduced 2.37%	5,081,895 $856 Million
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $12.4 Million - $16.8 Million	76,271 Added 1.49%	5,205,155 $881 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $4.01 Million - $6.4 Million	24,998 Added 0.49%	5,128,884 $960 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $29.9 Million - $39.9 Million	212,282 Added 4.34%	5,103,886 $829 Million
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $3.41 Million - $5.46 Million	-21,165 Reduced 0.43%	4,891,604 $920 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $10.3 Million - $12.6 Million	41,509 Added 0.85%	4,912,769 $1.3 Billion
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $4.44 Million - $7.38 Million	-22,771 Reduced 0.47%	4,871,260 $1.41 Billion
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $812 Million - $1.08 Billion	4,894,031 New	4,894,031 $977 Million

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.7M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.43B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Repligen Corp Transaction History